PEG-exenatide
- Generic Name
- PEG-exenatide
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-119 Injection in Chinese Obese Subjects
- First Posted Date
- 2024-04-05
- Last Posted Date
- 2024-06-13
- Lead Sponsor
- PegBio Co., Ltd.
- Target Recruit Count
- 32
- Registration Number
- NCT06350812
- Locations
- 🇨🇳
The Third XIANGYA Hospital of Central South University, Changsha, Hunan, China
Study to Evaluate the Pharmacokinetic Characteristics of Pegylated Exenatide Injection (PB-119) in Subjects With Different Degrees of Renal Insufficiency and Matched Subjects With Normal Renal Function
- First Posted Date
- 2022-04-14
- Last Posted Date
- 2022-04-14
- Lead Sponsor
- PegBio Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT05328843
- Locations
- 🇨🇳
Jia Miao, Chengdu, Sichuan, China
A Study With NLY01 in Subjects With Type 2 Diabetes
Phase 2
Completed
- Conditions
- Type2 DiabetesDiabetes Mellitus, Type 2
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-11-12
- Last Posted Date
- 2021-03-02
- Lead Sponsor
- Neuraly, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT04159766
- Locations
- 🇩🇪
Profil Institute, Neuss, Germany
🇩🇪Profil Institute fur Stoffwechselforschung GmbH, Neuss, Germany
A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease
- First Posted Date
- 2019-11-06
- Last Posted Date
- 2022-11-17
- Lead Sponsor
- Neuraly, Inc.
- Target Recruit Count
- 255
- Registration Number
- NCT04154072
- Locations
- 🇺🇸
Augusta University, Augusta, Georgia, United States
🇺🇸University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇨🇦Toronto Western Hospital, Toronto, Ontario, Canada
A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects
- First Posted Date
- 2018-09-14
- Last Posted Date
- 2019-09-30
- Lead Sponsor
- Neuraly, Inc.
- Target Recruit Count
- 96
- Registration Number
- NCT03672604
- Locations
- 🇺🇸
ICON Early Phase Services/CRU, San Antonio, Texas, United States
Clinical Trial for PB-119 in Healthy Subjects (Phase I)
- First Posted Date
- 2014-03-11
- Last Posted Date
- 2017-02-14
- Lead Sponsor
- PegBio Co., Ltd.
- Target Recruit Count
- 70
- Registration Number
- NCT02084251
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath